These ‘Tumor transition’ cells showed enrichment of ‘glycolysis’ and ‘MYC targets V1’ pathways, which contribute to cell proliferation, growth and metabolism19,20 (Fig. 2c). The gene discussed is MYC; the disease is neoplasm.